Th1 cells are generally considered to protect the host against tumor development by secreting multiple cytokines, including IFN-γ and IL-2, and enhancing the recruitment and activity of CD8+ T cells and NK T cells (6–8). The gene discussed is CD8A; the disease is neoplasm.